Respirology Search

Respirology

Respirology

Home News Diseases Conferences Special Reports Multimedia

TUBERCULOSIS - PULMONARY

Tuberculosis (TB) suspect is any one who has signs or symptoms suggestive of TB (eg >2 weeks productive cough).
Definite TB is considered in patients with culture or molecular line probe assay positive for Mycobacterium tuberculosis, or in patients with at least 1 sputum smear positive for acid-fast bacilli.
TB cases are also classified based on the disease anatomical site, bacteriological results (including drug resistance), previous treatment history and patient's HIV status.
Pulmonary TB is a case of TB that involves the lung parenchyma.
Miliary TB is considered as PTB since lung lesions are also seen.
TB in the pleural effusion, mediastinal and/or hilar lymph nodes with no evidence of abnormalities in the chest x-ray are considered extrapulmonary TB.
Patients presenting with both PTB and extrapulmonary TB are classified as a case of PTB.

Tuberculosis - Pulmonary Drug Information

Drug Information

Cravit/Cravit IV

Levofloxacin

Indication: Acute bacterial sinusitis, acute bacterial exacerbation of chronic bronchitis, community-acquired & nosoco...

MIMS Class: Quinolones

Daiichi Sankyo [ Ranbaxy ]

Zyvox

Linezolid

Indication: Nosocomial & community-acquired pneumonia including concurrent bacteremia; complicated & uncomplicated...

MIMS Class: Other Antibiotics

Pfizer [ Zuellig Pharma ]

Avelox

Moxifloxacin

Indication: Bacterial infections caused by susceptible strains: Community-acquired pneumonia, complicated skin & skin ...

MIMS Class: Quinolones

Bayer [ Zuellig Pharma ]

Flonoxin

Moxifloxacin

Indication: Acute bacterial sinusitis, acute exacerbations of chronic bronchitis, community-acquired pneumonia, complicate...

MIMS Class: Quinolones

Duopharma Manufacturing (Bangi) [ Duopharma Marketing ]

Glevo

Levofloxacin

Indication: Acute sinusitis, acute exacerbation of chronic bronchitis, community-acquired pneumonia, uncomplicated skin &a...

MIMS Class: Quinolones

Glenmark Pharma [ Uni Drug House ]

Levores

Levofloxacin

Indication: Mild, moderate & severe infections caused by levofloxacin-susceptible microorganisms in adults ≥18...

MIMS Class: Quinolones

Novell Pharma [ Averroes Pharma ]

Moxi 400

Moxifloxacin

Indication: Acute sinusitis & exacerbation of chronic bronchitis. Community-acquired pneumonia. Mild to moderately sev...

MIMS Class: Quinolones

Hetero Labs [ Unimed ]

Pharmaniaga Isoniazid

Isoniazid

Indication: In conjunction w/ other anti-TB drugs in the treatment of all forms of TB.

MIMS Class: Anti-TB Agents

Pharmaniaga Manufacturing Berhad [ Pharmaniaga Logistics ]

Akurit

MIMS Class: Anti-TB Agents

Akurit-4

MIMS Class: Anti-TB Agents

Mavrilimumab improves outcomes in COVID-19 pneumonia with hyperinflammation

Audrey Abella, 03 Aug 2020

Adding the anti-GM-CSF* receptor-α monoclonal antibody mavrilimumab to standard care (SC) improved clinical outcomes in patients with severe coronavirus disease 2019 (COVID-19) pneumonia and systemic hyperinflammation who were not under mechanical ventilation (MV), an Italian study has shown.

Oral as good as IV antibiotics for ridding P aeruginosa in cystic fibrosis

Pearl Toh, 08 Dec 2020

Intravenous (IV) antibiotics are no better than oral antibiotics when it comes to eradicating Pseudomonas (P.) aeruginosa in children and adults with cystic fibrosis, yet are more costly than the latter, reveals the TORPEDO-CF study.